We are live on ! Find out more
APLM icon

Apollomics

4 hedge funds and large institutions have $224K invested in Apollomics in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,327% more capital invested

Capital invested by funds: $9.22K → $224K (+$215K)

0.46% more ownership

Funds ownership: 0.03%0.49% (+0.46%)

0% more funds holding

Funds holding: 44 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$161K

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$6.81K
2
UBS Group
UBS Group
Switzerland
-$2.12K

APLM Hedge Fund Activity: Q2 2026 in Review

4 of the 8,320 institutional investors tracked by Wall St. Rank reported a position in Apollomics (APLM) for Q2 2026, worth a combined $224K — up 2,327% from $9.22K a quarter earlier.

Fund positioning in APLM was balanced in Q2 2026: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $161K. The largest seller was Citigroup, exiting entirely with an estimated $6.81K sold.

  • 4 institutional investors held Apollomics (APLM) as of Q2 2026, unchanged from Q1 2026.
  • Funds reported $224K of Apollomics stock for Q2 2026, up 2,327% quarter-over-quarter.
  • 1 fund opened new Apollomics positions in Q2 2026 and 1 closed out, a net change of 0 holders.
  • The largest Apollomics buyer in Q2 2026 was Citadel Advisors, an estimated $161K added.
  • The largest Apollomics seller in Q2 2026 was Citigroup, an estimated $6.81K sold.

Based on aggregated 13F filings for Q2 2026.